ConductScience.org, home

Disease · MONDO_0000262

Trials11

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.

TrialTitlePhaseParticipantsResults first postedConditionsDrugsLinked bySource
NCT04432376Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)Phase 2/33822022-11-04OtomycosisMICONAZOLEIts record names the diseaseClinicalTrials.gov
NCT01993823Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of OtomycosisPhase 31902017-02-13OtomycosisCLOTRIMAZOLEIts record names the diseaseClinicalTrials.gov
NCT03130738Dose-Ranging Study for Miconazole Oil for Treatment of OtomycosisPhase 2652020-05-08OtomycosisMICONAZOLEIts record names the diseaseClinicalTrials.gov
NCT01547221Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis PatientsNot applicable120OtomycosisBORIC ACID, CLOTRIMAZOLEIts record names the diseaseClinicalTrials.gov
NCT05660382Phase III Efficacy and Safety Study of Miconazole Oil for OtomycosisPhase 3112OtomycosisMICONAZOLEIts record names the diseaseClinicalTrials.gov
NCT04824261Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.Not applicable100OtomycosisBORIC ACID, CLOTRIMAZOLEIts record names the diseaseClinicalTrials.gov
NCT06339294Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis TreatmentPhase 190OtomycosisCLOTRIMAZOLE, POVIDONE-IODINEIts record names the diseaseClinicalTrials.gov
NCT07295210Boric Acid Versus 10% Povidone Iodine Solution in Treatment of OtomycosisNot applicable60OtomycosisBORIC ACID, POVIDONE-IODINEIts record names the diseaseClinicalTrials.gov
NCT07535424Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in OtomycosisNot applicable60OtomycosisCLOTRIMAZOLE, SALICYLIC ACIDIts record names the diseaseClinicalTrials.gov
NCT07152327Terbinafine Hydrochloride for the Treatment of OtomycosisNot applicable50Otomycosis, Fungal Ear InfectionTERBINAFINE HYDROCHLORIDEIts record names the diseaseClinicalTrials.gov
NCT04768829Antifungal Potential of Moringa Olifera Against OtomycosisEarly phase 110OtomycosisNYSTATINIts record names the diseaseClinicalTrials.gov

diseases-2026-09-18-0.1.0

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0000262/trials